PLMA_1170x120_7-2-21

The Association for Accessible Medicines

AAM issues statement on President Biden’s Supply Chain Executive Order

AAM issues statement on President Biden’s Supply Chain Executive Order

WASHINGTON — The Association for Accessible Medicines strongly supports President Biden’s America’s Supply Chains Executive Order as an important step toward strengthening the U.S. pharmaceutical supply chain and improving patient access to lower-cost generic and biosimilar medicines. The Executive Order is a prudent, considered approach to fully understanding the scope and capacity of current U.S.

AAM issues statement on President-elect Biden naming Katherine Tai as U.S. trade representative

AAM issues statement on President-elect Biden naming Katherine Tai as U.S. trade representative

WASHINGTON — The Association for Accessible Medicines and its members look forward to working with President-elect Biden’s U.S. Trade Representative (USTR)-designee Katherine Tai to ensure that U.S. trade policy promotes the proper balance between pharmaceutical innovation and off-patent competition that expands patient access to medicines and reduces health care costs. USTR-designee Tai was an instrumental leader